Evidence map›Paper›PMID 32140897›Full record

ReviewJournal of gastrointestinal cancer2020

Anticancer Effects of Herbal Medicine Compounds and Novel Formulations: a Literature Review.

Manal Khalid Abdulridha, Ali H Al-Marzoqi, Ghaidaa Raheem Lateef Al-Awsi, Shaden M H Mubarak, Maryam Heidarifard, Abdolmajid Ghasemian

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of gastrointestinal cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
4.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 53 citations in OpenAlex.

  1. Pooled it
  2. SingleInternational journal of oncology · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Biomedical reports · 2024
    Review
  10. Iranian journal of medical sciences · 2024
    Article
  11. Investigating the Effects ofAnti-cancer agents in medicinal chemistry · 2024
    Article
  12. Review
  13. Genistein: a promising modulator of apoptosis and survival signaling in cancer.Naunyn-Schmiedeberg's archives of pharmacology · 2023
    Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 2 countries.

Manal Khalid AbdulridhaDepartment of Clinical Pharmacy/College of Pharmacy, Mustansiriyah University, Baghdad, Iraq.
Ali H Al-MarzoqiDepartment of Biology, College of Science for women, University of Babylon, Hillah, Iraq.
Ghaidaa Raheem Lateef Al-AwsiCollege of Biotechnology, University of Al-Qadisiyah, Al-Qadisiyah, Iraq.
Shaden M H MubarakDepartment of Biochemistry, University of Kufa, Kufa, Iraq.
Maryam HeidarifardDepartment of Biochemistry, University of Kufa, Kufa, Iraq.
Abdolmajid GhasemianDepartment of Biology, Central Tehran Branch, Islamic Azad University, Tehran, Iran. majidghasemian86@gmail.com.
University of Kufa · IQIslamic Azad University Central Tehran Branch · IRMustansiriyah University · IQUniversity of Al-Qadisiyah · IQUniversity of Babylon · IQ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionMany agents disrupt the cell cycle and its signaling circuits leading to cancer progress. Cancer therapy is performed by surgery, radiation, and chemical drugs remaining some side effects.

objectiveTo evaluate the anticancer traits of herbal medicines.

methodsWe collected previously published data in searching engines (Web of Science, PubMed, Medline, and SCOPUS) by searching key words "herbal medicine," "anticancer effect," "compounds," and "fractions."

resultsHerbal medicines have unraveled anticancer effects mostly through cancer cells apoptosis via blocking NF-κB pathway by curcumin and terpenoides; CD95 signaling and enhancement of CD95L expression by resveratrol; and inhibiting tyrosine kinas, angiogenesis, and cell cycle arrest in G2/M phase by β-lapachone-genistein and cytochrome-c release into the cytosol and caspase-9 activation by biocalein and quercetin. Additionally, impeding cell cycle in the G1 phase in ovarian cancer cells by 7-hydroxystaurosporine, immune cells enrichment (neutrophils and NK cells activation by Viscum album L., T cells and NK cells activation and cytokines such as tumor necrosis factor release by Ganoderma lucidum and microRNAs regulation (by Sinomeniumacutum, shikonin, Oleaeuropaea, curcumin and ginseng). These effects have implications for proper cancer cells elimination. It has been revealed that cytotoxic effects of herbal compounds (mostly those secondary metabolites) have exerted anticancer properties against several cancer cell lines. In addition, targeting microRNAs, nanoparticle-assisted herbal synergism, and novel drug delivery systems and combination chemotherapies have also emerged exerting higher efficacies for specific cell targeting as novel cancer therapy approaches.

conclusionConsidering side effects, toxicity, and higher costs of common cancer therapy approaches, application of novel herbal medicine-based therapies will confer promising insights for health outcomes.

Indexed as

Antineoplastic Agents, PhytogenicApoptosisCell Cycle CheckpointsCell Line, TumorCell ProliferationDrug CarriersGene Expression Regulation, NeoplasticHumansMicroRNAsNanoparticlesNeoplasmsPhytotherapyPlant PreparationsSignal TransductionAntineoplastic Agents, PhytogenicDrug CarriersMicroRNAsPlant PreparationsAnticancer herbal medicineApoptosisCancer cellsmicroRNAsNanoparticles

Identifiers

PMID32140897
OpenAlexW3010044481

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.